CN Patent

CN1303674A — 阿普唑仑鼻喷剂

Assigned to MEDICINE INDUSTRY INST SHANDONG PROV · Expires 2001-07-18 · 25y expired

What this patent protects

一种苯二氮类药物——阿普唑仓鼻喷剂,由主药阿普唑仓、药用溶剂和其它药用辅料组成。根据药物的作用特点和理化性质,以及鼻腔给药的特点,本发明可分为溶液型、混悬型、凝胶型、乳液型。本发明给药方便,起效快,吸收完全,可用于癫痫持续状态(SE)及癫痫的治疗。

USPTO Abstract

一种苯二氮类药物——阿普唑仓鼻喷剂,由主药阿普唑仓、药用溶剂和其它药用辅料组成。根据药物的作用特点和理化性质,以及鼻腔给药的特点,本发明可分为溶液型、混悬型、凝胶型、乳液型。本发明给药方便,起效快,吸收完全,可用于癫痫持续状态(SE)及癫痫的治疗。

Drugs covered by this patent

naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.

Patent Metadata

Patent number: CN1303674A
Jurisdiction: CN
Classification: —
Expires: 2001-07-18
Drug substance claim: No
Drug product claim: No
Assignee: MEDICINE INDUSTRY INST SHANDONG PROV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.